Date: 06 November 2018
The Cancer Research Excellence in Surgical Trials (CREST) award was presented to the Breast Surgical Team at Queen Elizabeth Hospital NHS Foundation Trust, King’s Lynn, at the BASO (British Association of Surgical Oncologists) and NCRI (National Cancer Research Institute) Cancer Conference yesterday (5 November 2018).
The General Surgery Research Team at Queen Elizabeth Hospital Birmingham and CRN Thames Valley and South Midlands Direct Delivery Team at Nuffield Orthopaedic Hospital were both commended as runners up.
The award is managed by the NIHR Clinical Research Network and supported by Swann-Morton. Now in its fifth year, the award is presented to the surgical oncology team that has made the greatest contribution in recruitment to the NIHR cancer trials portfolio.
Professor Richard Shaw, NIHR National Specialty Lead for Surgical Oncology who presented the award said:
“The recipient of the CREST award 2018 is the Breast Surgery Team at Queen Elizabeth Hospital NHS Foundation Trust, King’s Lynn. As a smaller District General Hospital in a rural area, it is impressive to see the high number of patients recruited across a portfolio of many breast cancer trials. These trials include interventional studies such as POSNOC, PRIMETIME and ADD-ASPIRIN and the numbers of patients recruited to the NIHR Portfolio matches or exceeds many larger hospitals.
“The team also screen patients for other trials, directing them where possible to neighbouring larger trusts in order to improve access for their patients to other complex trials with demanding inclusion criteria. They have shown a significant contribution to the health of their local population, and also to the national collaborative efforts to enhance outcomes for patients with breast cancer.
“The CREST commendations for 2018 have excelled in trial recruitment but also in areas of innovation and leadership. Firstly to the Thames Valley and South Midlands Direct Delivery Team at the Nuffield Orthopaedic Hospital, who have implemented a novel approach over the last few years by creating a distinct team across their region to deliver the surgical portfolio. In doing so they have greatly increased recruitment and access to trials for patients.
“We also have awarded a commendation to the General Surgery Research Team based at the Queen Elizabeth Hospital Birmingham. Not only have they demonstrated consistently impressive trial recruitment, but also have shown great leadership locally, regionally and nationally in educational and trainee-led initiatives in surgical trial recruitment.”
Swann-Morton Limited is proud to offer their ongoing support to the CREST award and congratulate the team from King’s Lynn in recognition of their research studies and trials in the field of breast surgery.
The NCRI Cancer Conference continues today. NIHR is presenting the Making the UK a global leader in palliative care research by 2022 Igloo session this afternoon at 16:05 and is exhibiting, come and visit us at stand 22.
Photo credit: Simon Callaghan Photography
You may also be interested in